Trademark: 97535267
Status Date
Tuesday, December 12, 2023
Filing Date
Thursday, August 4, 2022
Published for Opposition
Tuesday, July 4, 2023
5 pharmaceutical products, namely, budesonide oral suspension (or BOS) for eosinophilic esophagitis (EoE)
Dec 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 12, 2023
Sou Extension 1 Granted
Dec 12, 2023
Sou Extension 1 Filed
Dec 12, 2023
Sou Teas Extension Received
Aug 29, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 4, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 4, 2023
Published For Opposition
Jun 14, 2023
Notification Of Notice Of Publication E-Mailed
Jun 1, 2023
Approved For Pub - Principal Register
Jun 1, 2023
Examiner's Amendment Entered
Jun 1, 2023
Notification Of Examiners Amendment E-Mailed
Jun 1, 2023
Examiners Amendment E-Mailed
Jun 1, 2023
Examiners Amendment -Written
May 30, 2023
Notification Of Non-Final Action E-Mailed
May 30, 2023
Non-Final Action E-Mailed
May 30, 2023
Non-Final Action Written
May 25, 2023
Previous Allowance Count Withdrawn
May 25, 2023
Approved For Pub - Principal Register
May 22, 2023
Assigned To Examiner
Aug 25, 2022
New Application Office Supplied Data Entered
Aug 8, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
